Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C16H24FNO · HCl
CAS Number:
Molecular Weight:
301.83
UNSPSC Code:
12352200
PubChem Substance ID:
MDL number:
assay
≥98% (HPLC)
form
solid
color
white
solubility
H2O: >20 mg/mL, ethanol: soluble
SMILES string
Cl[H].CCCN(CCC)[C@H]1CCc2c(F)ccc(O)c2C1
InChI
1S/C16H24FNO.ClH/c1-3-9-18(10-4-2)12-5-6-13-14(11-12)16(19)8-7-15(13)17;/h7-8,12,19H,3-6,9-11H2,1-2H3;1H/t12-;/m0./s1
InChI key
FKUVCCNCUAFKAH-YDALLXLXSA-N
Gene Information
human ... HTR1A(3350)
Biochem/physiol Actions
Potent, selective 5-HT1A serotonin receptor antagonist; D2/D3 dopamine receptor agonist.
Preparation Note
S(-)-UH-301 hydrochloride is soluble in water (>20 mg/ml) and ethanol.
Disclaimer
hygroscopic, photosensitive
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
L Björk et al.
European journal of pharmacology, 199(3), 367-370 (1991-07-09)
The 5-HT1A-receptor antagonist (S)-UH-301 (S)-5-fluoro-8-hydroxy-2- (dipropylamino)tetralin) completely antagonized the hypotension and bradycardia induced by (R) = 8-OH DPAT [R)-8-hydroxy-2- (dipropylamino)tetralin) in conscious rats. (S)-UH-301 alone induced a weak hypertension, which might be due to its 5-HT1A-receptor antagonistic properties. (R)-UH-301 induced
Synthesis and pharmacology of the enantiomers of UH301: opposing interactions with 5-HT1A receptors.
S E Hillver et al.
Chirality, 8(8), 531-544 (1996-01-01)
The (S)-enantiomer of 5-fluoro-8-hydroxy-2-(dipropylamino) tetralin [(S)-2a; (S)-UH301] was the first reported 5-HT1A receptor antagonist. We now give a full account on the synthetic effort leading to the preparation of the racemate and the enantiomers of 2a. The crystal and molecular
S Ahlenius et al.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 9(1-2), 15-19 (1999-03-19)
The receptor-mediated control of brain monoamine synthesis was used to examine the in vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, S(-)-UH-301 and WAY-100,635. The rate of monoamine synthesis was estimated by measuring the accumulation of DOPA and 5-HTP
L Björk et al.
The Journal of pharmacology and experimental therapeutics, 258(1), 58-65 (1991-07-01)
The selective 5-hydroxytryptamine (5-HT1A) receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH-DPAT) induces a large number of pharmacological effects. In the present study we demonstrate that a novel 8-OH-DPAT analog, (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin [(S)-UH-301], is able to antagonize completely the following (R)-8-OH-DPAT-induced effects in the rat:
L Arborelius et al.
Naunyn-Schmiedeberg's archives of pharmacology, 347(4), 353-362 (1993-04-01)
The effects of the selective 5-HT1A receptor agonist (R)-8-hydroxy-2(di-n-propylamino)tetralin [(R)-8-OH-DPAT] and the novel 5-HT1A antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)-tetralin [(S)-UH-301] were studied with regard to the firing pattern of single mesencephalic dopamine (DA) neurons with extracellular recording techniques in chloral hydrate anesthetized male
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service